State University of New York Upstate Medical University
David P. Schenkein, M.D. - Senior Vice President Clinical Hematology/Oncology at Genentech Inc. (San Francisco, CA); Former Senior Vice President of Oncology Clinical Development at Millennium Pharmaceuticals Inc. and developer of cancer drug Velcade